188 related articles for article (PubMed ID: 17103306)
21. Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus.
Huo X; Zhang HY; Zhang XI; Lynch JP; Strauch ED; Wang JY; Melton SD; Genta RM; Wang DH; Spechler SJ; Souza RF
Gastroenterology; 2010 Jul; 139(1):194-203.e1. PubMed ID: 20303354
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux.
Csendes A; Smok G; Burdiles P; Quesada F; Huertas C; Rojas J; Korn O
Dis Esophagus; 2000; 13(1):5-11. PubMed ID: 11005324
[TBL] [Abstract][Full Text] [Related]
23. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus.
Ormsby AH; Vaezi MF; Richter JE; Goldblum JR; Rice TW; Falk GW; Gramlich TL
Gastroenterology; 2000 Sep; 119(3):683-90. PubMed ID: 10982762
[TBL] [Abstract][Full Text] [Related]
24. Transitional basal cells at the squamous-columnar junction generate Barrett's oesophagus.
Jiang M; Li H; Zhang Y; Yang Y; Lu R; Liu K; Lin S; Lan X; Wang H; Wu H; Zhu J; Zhou Z; Xu J; Lee DK; Zhang L; Lee YC; Yuan J; Abrams JA; Wang TC; Sepulveda AR; Wu Q; Chen H; Sun X; She J; Chen X; Que J
Nature; 2017 Oct; 550(7677):529-533. PubMed ID: 29019984
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
Jankowski J; Hopwood D; Pringle R; Wormsley KG
Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
[TBL] [Abstract][Full Text] [Related]
26. Absence of Na+/sugar cotransport activity in Barrett's metaplasia.
Murray LJ; Tully O; Rudolph DS; Whitby M; Valenzano MC; Mercogliano G; Thornton JJ; Mullin JM
World J Gastroenterol; 2008 Mar; 14(9):1365-9. PubMed ID: 18322949
[TBL] [Abstract][Full Text] [Related]
27. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
Phillips RW; Frierson HF; Moskaluk CA
Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide could promote development of Barrett's esophagus by
Fujiya T; Asanuma K; Koike T; Okata T; Saito M; Asano N; Imatani A; Masamune A
Am J Physiol Gastrointest Liver Physiol; 2022 Jan; 322(1):G107-G116. PubMed ID: 34786954
[TBL] [Abstract][Full Text] [Related]
29. [Specialized intestinal metaplasia of the distal esophagus in gastroesophageal reflux disease: prevalence and clinico-demographic features].
Caum LC; Bizinelli SL; Pisani JC; Amarantes HM; Ioshii SO; Carmes ER
Arq Gastroenterol; 2003; 40(4):220-6. PubMed ID: 15264043
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of intestinal metaplasia in the gastric cardia.
El-Serag HB; Sonnenberg A; Jamal MM; Kunkel D; Crooks L; Feddersen RM
Am J Gastroenterol; 1999 Mar; 94(3):622-7. PubMed ID: 10086641
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus.
Sarosi G; Brown G; Jaiswal K; Feagins LA; Lee E; Crook TW; Souza RF; Zou YS; Shay JW; Spechler SJ
Dis Esophagus; 2008; 21(1):43-50. PubMed ID: 18197938
[TBL] [Abstract][Full Text] [Related]
32. Molecular defense mechanisms of Barrett's metaplasia estimated by an integrative genomics.
Ostrowski J; Mikula M; Karczmarski J; Rubel T; Wyrwicz LS; Bragoszewski P; Gaj P; Dadlez M; Butruk E; Regula J
J Mol Med (Berl); 2007 Jul; 85(7):733-43. PubMed ID: 17415542
[TBL] [Abstract][Full Text] [Related]
33. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus.
DeMeester SR; Wickramasinghe KS; Lord RV; Friedman A; Balaji NS; Chandrasoma PT; Hagen JA; Peters JH; DeMeester TR
Am J Gastroenterol; 2002 Oct; 97(10):2514-23. PubMed ID: 12385432
[TBL] [Abstract][Full Text] [Related]
34. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
[TBL] [Abstract][Full Text] [Related]
35. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
36. The prevalence of intestinal metaplasia in patients with and without peptic strictures.
Kim SL; Wo JM; Hunter JG; Davis LP; Waring JP
Am J Gastroenterol; 1998 Jan; 93(1):53-5. PubMed ID: 9448174
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiology of Barrett's esophagus.
Chandrasoma P
Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):270-8. PubMed ID: 9263345
[TBL] [Abstract][Full Text] [Related]
38. The expression of 8-hydroxydeoxyguanosine in oesophageal tissues and tumours.
Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA
Eur J Surg Oncol; 2007 Dec; 33(10):1164-8. PubMed ID: 17467227
[TBL] [Abstract][Full Text] [Related]
39. Trefoil Factor Expression in a Human Model of the Early Stages of Barrett's Esophagus.
Dunn LJ; Jankowski JA; Griffin SM
Dig Dis Sci; 2015 May; 60(5):1187-94. PubMed ID: 25424203
[TBL] [Abstract][Full Text] [Related]
40. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present.
Singh P; Taylor RH; Colin-Jones DG
Am J Gastroenterol; 1994 Mar; 89(3):349-56. PubMed ID: 8122643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
